Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 76 results found. Search for [ bharat biotech covaxin phase 3 results ]

Results 60 to 76 of 76
BusinessToday.In
August 9, 2020
Coronavirus vaccine update: The pandemic is putting pressure on the company to come out with a vaccine quickly, but we cannot rush as safety and quality are paramount, says Krishna M Ella


BusinessToday.In
August 4, 2020
Coronavirus vaccine update: Jeevan Rekha Hospital was among the 12 facilities selected by the ICMR to conduct human trials of Covaxin


Joe C Mathew
August 3, 2020
Indian vaccine manufacturers are waiting for a vaccination plan from the government so that they can set aside stocks of vaccines when they are approved for production


BusinessToday.In
July 28, 2020
Coronavirus vaccine news: Serum Institute of India CEO Adar Poonawalla had earlier stated that the company would reserve 50 per cent of the vaccine doses for use in India


PTI
July 28, 2020
Coronavirus vaccine news: Doses of the vaccine were given to 1,077 healthy adults aged between 18 and 55 in five UK hospitals in April and May as part of Phase 1 clinical trial and results, published in The Lancet medical journal


BusinessToday.In
July 23, 2020
Coronavirus (Covid-19) Vaccine News Latest Updates: Head of WHO's emergencies programme Mike Ryan has said that while there are multiple contenders and many companies have made significant progress, the likely time for a coronavirus vaccine in the market is not before 2021


BusinessToday.In
July 22, 2020
Coronavirus (COVID-19) Vaccine News Latest Updates: Dr Cyrus Poonawalla, Chairman of the Poonawalla Group, says a just a few million doses of the potential COVID-19 vaccine will not be enough and the company intends to manufacture around 1 billion doses after getting all the necessary approvals


Chitranjan Kumar
July 21, 2020
Share market updates and analysis for July 22: Corporate earnings announcements, coronavirus vaccine hopes and global cues to set tone for stock markets


BusinessToday.In
July 21, 2020
Vaccine major Serum Institute of India's CEO Adar Poonawalla said on Monday the company will apply for COVID-19 vaccine trials within a week and will soon begin manufacturing the vaccine, developed by Oxford University, in large volumes


BusinessToday.In
July 20, 2020
COVAXIN is the first indigenous coronavirus vaccine, being developed by Hyderabad-based Bharat Biotech and Indian Council of Medical Research (ICMR). AIIMS, Delhi is one of the 12 facilities shortlisted by ICMR for conducting clinical trials of Covaxin


BusinessToday.In
July 20, 2020
Coronavirus vacciine update: Trials on 1,077 people showed that the vaccine, officially known as AZD1222, led to generation of antibodies and white blood cells that can fight coronavirus


BusinessToday.In
July 17, 2020
Coronavirus vaccine: The human trial of COVAXIN has started in All India Institute of Medical Sciences in Patna and Post-Graduate Institute of Medical Sciences in Rohtak


BusinessToday.In
July 3, 2020
Coronavirus vaccine update: ICMR asked the institutes to ensure that all the subjects are enrolled starting this week and to speed up approvals


BusinessToday.In
July 3, 2020
Maharashtra Mumbai, Delhi Coronavirus (COVID-19) cases, Lockdown News Pune, Thane Live Updates: ICMR writes to Bharat Biotech to conclude trials of COVID-19 vaccine in order to launch the results by August 15. India's total coronavirus cases jumped to 6,25,544 on Friday. Maharashtra's tally is past 1.86 lakh while Tamil Nadu and Delhi count stands at 98,392 and 92,175


E Kumar Sharma
July 1, 2020
Bharat Biotech isn't committing a timeline, but considering the necessary processes, and if COVAXIN does not fail at any stage, the earliest it could hit the market is late 2021


BusinessToday.In
June 30, 2020
Coronavirus vaccine update: The Hyderabad-based vaccine major's vaccine candidate COVAXIN has received permission for advancing to human trials


E Kumar Sharma
June 29, 2020
DCGI has allowed Bharat Biotech to conduct phase I and II human trials for COVAXIN that will begin in July; a finished vaccine is expected to be rolled out in 3-4 months if all goes according to plan


PAGES 4 OF 4  1234